Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NervGen Pharma Corp V.NGEN

Alternate Symbol(s):  NGENF

NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. It has also initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury. The Company's wholly owned subsidiaries include NervGen US Inc. and NervGen Australia Pty Ltd.


TSXV:NGEN - Post by User

Post by stargazer1on Dec 27, 2023 3:43pm
251 Views
Post# 35801661

Goodness

GoodnessTwo years ago, November 2021, the stock reached an all time high of $2.49. 

We have reached $2.23 already, on almost a quarter of a million shares traded. Yesterday we were in the $1 range.

We may yet surpass our previous high this week. Just think about how high we might go in 2024.
High ho, high ho, it's off to work we go.

Appologies to the seven dwarfs.

But really. THINK ABOUT IT. 2024 may make a lot of people very very rich, or at least those that took a chance and bought shares here. 

I admit that I am not an expert, but all things considered, when looking at this stock, its price could go up 50X from here, or even higher. And this is a realistic possibility. 

A stock like this comes around maybe once in a life time. And we are in it before it takes off.  

When I said Goodness, I really did mean Goodness.
<< Previous
Bullboard Posts
Next >>